Pricing Log in Create free account

Neptune Wellness Solutions Inc. (NEPTF) vs PainReform Ltd. (PRFX)

Neptune Wellness Solutions Inc. and PainReform Ltd. are both Drug Manufacturers Specialty & Generic companies. PainReform Ltd. is the larger, with a market value of $2.6M against $1.6M — 1.6× the size. PainReform Ltd. has the higher net margin (0.00% vs −135.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, PainReform Ltd. leads on 7 and Neptune Wellness Solutions Inc. on 5.

Valuation

Metric NEPTF PRFX Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S n/m n/m 2.11
P/B n/m 0.00 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m 0.97 12.58
EV/Sales 1.06 n/m 2.73
Earnings yield 0.00% (73,121.23%) (4.38%)
Free cash flow yield 0.00% (95,565.78%) 0.00%

Profitability

Metric NEPTF PRFX Drug Manufacturers Specialty & Generic median
Gross margin (1.94%) 0.00% 53.94%
Operating margin (190.39%) 0.00% 0.00%
Net margin (135.24%) 0.00% 0.00%
Free cash flow margin (40.57%) 0.00% 0.00%
Return on equity 291.47% 0.00% (0.40%)
Return on assets (121.62%) 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NEPTF PRFX Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (24.78%) — 10.01%
EPS growth (last fiscal year) 67.05% 92.92% 49.06%
Revenue growth, 5-year CAGR 19.52% — 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NEPTF PRFX Drug Manufacturers Specialty & Generic median
Debt to equity (0.50) 0.00 0.05
Current ratio 0.23 5.07 2.31
Net debt to EBITDA (0.21) 0.96 0.97

Dividend

Metric NEPTF PRFX Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric NEPTF PRFX Drug Manufacturers Specialty & Generic median
Market cap 1.60m 2.57m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack